Cited by 26Advanced biosensing and bioanalysis techniquesAlzheimer's disease research and treatmentsBiosensors and Analytical Detection

Dumbbell Aptamer Sensor Based on Dual Biomarkers for Early Detection of Alzheimer’s Disease

Zhou, Jie, Sun, Yiwen, Zhang, Jin, Luo, Fusui, Ma, Huili, Guan, Min, Feng, Junfen, Dong, Xiaomeng·2023·ACS Applied Materials & Interfaces

Abstract

Finding a timely, sensitive, and noninvasive detection method has become an urgent need for asymptomatic early diagnosis of Alzheimer's disease (AD). MicroRNA-193b (miR-193b) and Aβ42 oligomers (AβO42) in neurogenic exosomes were confirmed to reflect pathological changes in the AD early stage. The combination of two biomarkers is promising for the earlier detection of AD. In this study, a detection system based on the principle of the entropy-driven strand displacement reaction (ESDR) was developed, including a dumbbell detection probe (H), an indicator probe (R), and graphene oxide (GO). In the detection system, the two hairpins of H were opened by the interaction of miR-193b (T1) and AβO42 (T2) with the aptamer. Then R hybridized with H and began to displace T, initiating the next round of ESDR to achieve sensitive detection of T. GO specifically adsorbed free R and quenched the fluorescence, further reducing the intensity of the background signal. Both of these points provided the system with a more sensitive analytical performance. The detection limit of miR-193b was 77 pM and the detection limit of AβO42 was 53 pM. This sensor detected the change of "one increase (AβO42) and one decrease (miR-193b)" in the exosome sample. Additionally, results showed that this detection system could distinguish the model of early AD from the non-AD control, which was sufficient for earlier and more sensitive detection of AD. This strategy has strong specificity, high sensitivity, and easy operation, which provides broad prospects for the early diagnosis of AD.

Integrity signals

Registry

Crossref · 10.1021/acsami.2c21379

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zhou and colleagues developed a highly sensitive and non-invasive fluorescent biosensor for simultaneously detecting neurogenic exosomes-derived miRNA-193b and Aβ42 oligomers (AβO42) associated with early Alzheimer's disease.

    “Recently, Zhou and colleagues have advanced the field of diagnostics with the development of a highly sensitive and non-invasive fluorescent biosensor for simultaneously detecting two critical biomarkers associated with the early stages of AD [236], as illustrated in Fig. 3b.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhou, J., Sun, Y., Zhang, J., Luo, F., Ma, H., Guan, M., Feng, J., & Dong, X.
Affiliations
Zhengzhou University (CN)
Corresponding author
Zhou, Jie
Venue
ACS Applied Materials & Interfaces
Published
2023-03-23
Volume
15
Issue
13
Pages
16394-16407
ISSN
  • 1944-8244 (ISSN-L)
  • 1944-8252
OpenAlex
W4360600710
Cited by
26
References
41
Citations by year
2026: 6 · 2025: 12 · 2024: 6 · 2023: 2
FWCI
2.31
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Applied Materials & Interfaces (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (U1904135)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
Keywords
Alzheimer's disease, early diagnosis, aptasensor, amyloid-beta oligomers, exosomes, graphene oxide, fluorescence quenching, nucleic acid biosensors
MeSH terms
Alzheimer Disease, Graphite, Humans, Biosensing Techniques, Biomarkers, MicroRNAs, Early Diagnosis, Aptamers, Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review